These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 31653191

  • 1. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
    Nieto-Aristizábal I, Martínez T, Urbano MA, Posso-Osorio I, Plata IF, Garcia-Robledo JE, Aragón CC, Santos VA, Tobón GJ.
    Lupus; 2019 Nov; 28(13):1566-1570. PubMed ID: 31653191
    [Abstract] [Full Text] [Related]

  • 2. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
    Camara I, Sciascia S, Simoes J, Pazzola G, Salas V, Karim Y, Roccatello D, Cuadrado MJ.
    Clin Exp Rheumatol; 2014 Nov; 32(1):41-7. PubMed ID: 24029366
    [Abstract] [Full Text] [Related]

  • 3. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
    Sherer Y, Kuechler S, Jose Scali J, Rovensky J, Levy Y, Zandman-Goddard G, Shoenfeld Y.
    Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
    [Abstract] [Full Text] [Related]

  • 4. Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.
    Sakthiswary R, D'Cruz D.
    Medicine (Baltimore); 2014 Oct; 93(16):e86. PubMed ID: 25310743
    [Abstract] [Full Text] [Related]

  • 5. A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
    Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y.
    Lupus; 1999 Oct; 8(9):705-12. PubMed ID: 10602441
    [Abstract] [Full Text] [Related]

  • 6. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
    Zandman-Goddard G, Levy Y, Shoenfeld Y.
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
    [Abstract] [Full Text] [Related]

  • 7. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study.
    Akca ÜK, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S.
    Lupus; 2021 Oct; 30(12):1983-1990. PubMed ID: 34459313
    [Abstract] [Full Text] [Related]

  • 8. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia].
    Zhang X, Dong Y, Tang F, Zhang F, Li H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):82-4. PubMed ID: 12903501
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study.
    Jiang Y, Zhao HJ, Luo H, Li BJ, Zhang ZM, Zhao LD, Zuo XX.
    Front Immunol; 2022 Feb; 13():861719. PubMed ID: 35757744
    [Abstract] [Full Text] [Related]

  • 10. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E, Kessel A, Shoenfeld Y.
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [Abstract] [Full Text] [Related]

  • 11. Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases.
    Zandman-Goddard G, Krauthammer A, Levy Y, Langevitz P, Shoenfeld Y.
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):247-55. PubMed ID: 21732045
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
    Brasileiro A, Fonseca Oliveira J, Pinheiro S, Paiva-Lopes MJ.
    Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
    [Abstract] [Full Text] [Related]

  • 13. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
    Sherer Y, Shoenfeld Y.
    Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
    [Abstract] [Full Text] [Related]

  • 14. Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases.
    Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L, Aral O, Konice M.
    Rheumatol Int; 2005 Apr; 25(3):211-4. PubMed ID: 14722731
    [Abstract] [Full Text] [Related]

  • 15. Hypogammaglobulinemia in pediatric systemic lupus erythematosus.
    Lim E, Tao Y, White AJ, French AR, Cooper MA.
    Lupus; 2013 Nov; 22(13):1382-7. PubMed ID: 24106215
    [Abstract] [Full Text] [Related]

  • 16. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
    Tufan F, Kamali S, Erer B, Gul A, Inanc M, Ocal L, Konice M, Aral O.
    Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
    [Abstract] [Full Text] [Related]

  • 17. [Polyvalent intravenous immunoglobulins in systemic lupus].
    Papo T.
    Rev Med Interne; 1999 Nov; 20 Suppl 4():414s-418s. PubMed ID: 10522315
    [Abstract] [Full Text] [Related]

  • 18. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
    Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X, Davis JC, Kennedy WP.
    Ann Rheum Dis; 2016 Jan; 75(1):196-202. PubMed ID: 26038091
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.
    Lazurova I, Macejova Z, Benhatchi K, Oetterová M, Antolová E, Asherson RA, Rovensky J.
    Clin Rheumatol; 2007 Dec; 26(12):2145-2147. PubMed ID: 17487450
    [Abstract] [Full Text] [Related]

  • 20. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
    Ma J, Zhang L, Yan M, Liu Z, Xue L.
    Lupus Sci Med; 2024 Jun 10; 11(1):. PubMed ID: 38862157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.